Latest News for: psyence

Edit

Psyence Group Inc. Provides Update on Proposed Amalgamation with GoldCoast Resource Corp.

ACCESSWIRE 18 Mar 2026
TORONTO, ON / ACCESS Newswire / March 17, 2026 / Psyence Group Inc. (CSE.PSYG) ("Psyence" or the "Company") announces that GoldCoast Resource Corp ... About Psyence Group Inc. Psyence Group Inc ... Psyence Group Inc.
Edit

Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone

Nasdaq Globe Newswire 11 Mar 2026
“The strongest companies are built on the right foundations long before their moment arrives,” says CEO Jody Aufrichtig. “The strongest companies are built on the right foundations long before their moment arrives,” says CEO Jody Aufrichtig ... .
Edit

Psyence BioMed Announces Export of GMP-Manufactured Natural Psilocybin (NPX-5) to Australia for Ongoing Phase IIb ...

Nasdaq Globe Newswire 03 Mar 2026
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd ... PBM) (“Psyence BioMed” or the ...
Edit

EXPLANATORY NOTE (Form 6-K) (Psyence Biomedical Ltd)

Public Technologies 02 Mar 2026
As previously disclosed in the Company's Report on Form 6-K furnished to the SEC on February 13, 2026, Psyence Labs Ltd ... business in now owned and operated by PsyLabs under the name "Psyence Production" ... Psyence Biomedical Ltd.
Edit

Psyence Group Inc. Enters into Amending Agreement to Extend Amalgamation Timeline with GoldCoast Resource Corp.

ACCESSWIRE 24 Feb 2026
("GoldCoast") and Psyence Therapeutics Corp., a wholly owned subsidiary of Psyence ("Psyence Subco"), to amend the definitive amalgamation agreement dated November 21, 2025 (the "Amalgamation ...
Edit

Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment

Nasdaq Globe Newswire 20 Feb 2026
20, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd ... PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company ...
Edit

Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment (Form 6-K) (Psyence Biomedical Ltd)

Public Technologies 20 Feb 2026
Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment. NEW YORK - February 20, 2026 - Psyence Biomedical Ltd ... About Psyence BioMed. Psyence Biomedical Ltd ... Contact Information for Psyence Biomedical Ltd.
Edit

Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders (Form 6-K) (Psyence Biomedical Ltd)

Public Technologies 19 Feb 2026
Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders. NEW YORK - February 13, 2026 - Psyence Biomedical Ltd ... About Psyence BioMed. Psyence Biomedical Ltd ... Contact Information for Psyence Biomedical Ltd ... Psyence Biomedical Ltd.
Edit

Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders

Nasdaq Globe Newswire 17 Feb 2026
17, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd ... PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company ...
Edit

Psyence BioMed Approves a Put Option Agreement with PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway (Form 6-K) (Psyence Biomedical Ltd)

Public Technologies 13 Feb 2026
Psyence BioMed Approves a Put Option Agreement with PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway ... NEW YORK - February 13, 2026 - Psyence Biomedical Ltd ... About Psyence BioMed. Psyence Biomedical Ltd ... Psyence Biomedical Ltd.
Edit

Psyence BioMed Approves Put Option Agreement with PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway

Nasdaq Globe Newswire 13 Feb 2026
The Put Option Agreement positions Psyence BioMed for potential significant future equity participation in one of the world's ...
Edit

Psyence BioMed Announces Settlement of Shareholder Litigation (Form 6-K) (Psyence Biomedical Ltd)

Public Technologies 12 Feb 2026
Psyence BioMed Announces Settlement of Shareholder Litigation. NEW YORK - February 11, 2026 - Psyence Biomedical Ltd ... About Psyence BioMed. Psyence Biomedical Ltd ... Contact Information for Psyence Biomedical Ltd ... Psyence Biomedical Ltd.
Edit

Psyence BioMed Announces Settlement of Shareholder Litigation

Nasdaq Globe Newswire 11 Feb 2026
11, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd ... PBM) ("Psyence BioMed" or the "Company") today announced that it has entered ...
Edit

Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split (Form 6-K) (Psyence Biomedical Ltd)

Public Technologies 29 Jan 2026
Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split. NEW YORK - January 28, 2026 - Psyence Biomedical Ltd ... About Psyence BioMed. Psyence Biomedical Ltd ... Contact Information for Psyence Biomedical Ltd ... Psyence Biomedical Ltd.
Edit

Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split

Nasdaq Globe Newswire 29 Jan 2026
28, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd ... PBM) (“Psyence BioMed” or the “Company”), today announced the effective date ...

Article Search

tools
×
×
×
×